Skip to search formSkip to main contentSkip to account menu

EM 523

Known as: EM-523, EM523L, Erythromycin, 8,9-didehydro-9-deoxo-6-deoxy-6,9-epoxy- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
EM523L, a newly developed erythromycin derivative, has a powerful motilin-like biologic effect and no antibacterial activity. In… 
1993
1993
We investigated the effect of an erythromycin derivative, EM523L, on interdigestive gastrointestinal motor activity and plasma… 
Highly Cited
1991
1991
1991
In this study, we investigated the effect of EM-523, one of the erythromycin derivatives, on gastrointestinal motility in… 
1991
1991
SummaryRecent studies suggested that certain erythromycin A (EM-A) derivatives are motilin receptor agonists. As proposed by Itoh…